Open-Label, Non-Mandatory Transitioning From Originator Etanercept to Biosimilar SB4: Six-Month Results From a Controlled Cohort Study

Lieke Tweehuysen, Victor J. B. Huiskes, Bart J. F. van den Bemt, Johanna E. Vriezekolk, Steven Teerenstra, Frank H. J. van den Hoogen, Cornelia H. van den Ende, Alfons A. den Broeder

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)1408-1418
Number of pages11
JournalArthritis & Rheumatology
Volume70
Issue number9
DOIs
Publication statusPublished - 1 Sep 2018

Keywords

  • NATIONWIDE NONMEDICAL SWITCH
  • RHEUMATOID-ARTHRITIS
  • DISEASE-ACTIVITY
  • SELF-EFFICACY
  • INFLAMMATORY ARTHRITIS
  • CLINICAL-OUTCOMES
  • DANBIO REGISTRY
  • INFLIXIMAB
  • EXPERIENCE
  • CT-P13

Cite this